Theratechnologies Inc. (TSE:TH - Get Free Report)'s share price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$1.72 and traded as low as C$1.70. Theratechnologies shares last traded at C$1.73, with a volume of 14,250 shares.
Theratechnologies Stock Performance
The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64. The stock has a 50-day moving average price of C$1.72 and a 200-day moving average price of C$1.81. The company has a market capitalization of C$78.63 million, a price-to-earnings ratio of -9.61, a PEG ratio of -8.50 and a beta of 1.73.
Theratechnologies (TSE:TH - Get Free Report) last issued its quarterly earnings data on Thursday, October 10th. The company reported C$0.09 earnings per share for the quarter. The company had revenue of C$30.96 million for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. As a group, analysts forecast that Theratechnologies Inc. will post 0.0298643 earnings per share for the current year.
About Theratechnologies
(
Get Free Report)
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Further Reading
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
